Mark Thomson is a Biotechnology Commercial Leader with extensive experience in the pharmaceutical industry. They served as Vice President of Marketing at Epizyme from 2020 to 2022 and held various positions at Johnson & Johnson, including Regional Business Director for Gastroenterology and several roles in oncology and immunology. Currently, Mark is the VP and Global Commercial Lead for IBD & TL1a at Sanofi, having also been the Global Lead for New Product Planning in GI and Rheumatology there. They earned an MBA in Marketing from UNC Kenan-Flagler Business School and a B.S. in Biology and Economics from Bates College.
Location
Boston, United States
This person is not in the org chart
This person is not in any teams
This person is not in any offices